The recent studies have revealed that most BRAF inhibitors can paradoxically induce kinase activation by promoting dimerization and enzyme transactivation. Despite rapidly growing number of structural and functional studies about the BRAF dimer complexes, the molecular basis of paradoxical activation phenomenon is poorly understood and remains largely hypothetical. In this work, we have explored the relationships between inhibitor binding, protein dynamics and allosteric signaling in the BRAF dimers using a network-centric approach. Using this theoretical framework, we have combined molecular dynamics simulations with coevolutionary analysis and modeling of the residue interaction networks to determine molecular determinants of paradoxical ...
The BRAF kinase, within the mitogen activated protein kinase (MAPK) signaling pathway, harbors activ...
Quantifying binding specificity and drug resistance of protein kinase inhibitors is of fundamental i...
Although RAF kinases are critical for controlling cell growth, their mechanism of activation is...
The recent studies have revealed that most BRAF inhibitors can paradoxically induce kinase activatio...
Treatment of cancer patients with ATP-competitive inhibitors of BRAF/CRAF kinases surprisingly incre...
Various BRAF kinase inhibitors were developed to treat cancers carrying the BRAFV600E mutation. Firs...
SummaryTreatment of cancer patients with ATP-competitive inhibitors of BRAF/CRAF kinases surprisingl...
Using quantitative proteomics we mapped the interactomes of RAF1 monomers, RAF1-BRAF and RAF1-BRAFV6...
The V600E missense mutation in B-Raf kinase leads to an anomalous regulation of the MAPK pathway, un...
International audienceThe mutation V600E in B-Raf leads to MAPK pathway activation, uncontrolled cel...
BRAF<sup>V600E</sup> is the most common activating mutation in melanoma and patients treated with BR...
As a central element within the RAS/ERK pathway, the serine/threonine kinase BRAF plays a key role ...
Despite the clinical success of BRAF inhibitors like vemurafenib in treating metastatic melanoma, re...
The RAF/MEK/ERK pathway is central to the control of cell physiology, and its dysregulation is assoc...
Tumors with mutant BRAF are dependent on the RAF/MEK/ERK signaling pathway for their growth1-3. We f...
The BRAF kinase, within the mitogen activated protein kinase (MAPK) signaling pathway, harbors activ...
Quantifying binding specificity and drug resistance of protein kinase inhibitors is of fundamental i...
Although RAF kinases are critical for controlling cell growth, their mechanism of activation is...
The recent studies have revealed that most BRAF inhibitors can paradoxically induce kinase activatio...
Treatment of cancer patients with ATP-competitive inhibitors of BRAF/CRAF kinases surprisingly incre...
Various BRAF kinase inhibitors were developed to treat cancers carrying the BRAFV600E mutation. Firs...
SummaryTreatment of cancer patients with ATP-competitive inhibitors of BRAF/CRAF kinases surprisingl...
Using quantitative proteomics we mapped the interactomes of RAF1 monomers, RAF1-BRAF and RAF1-BRAFV6...
The V600E missense mutation in B-Raf kinase leads to an anomalous regulation of the MAPK pathway, un...
International audienceThe mutation V600E in B-Raf leads to MAPK pathway activation, uncontrolled cel...
BRAF<sup>V600E</sup> is the most common activating mutation in melanoma and patients treated with BR...
As a central element within the RAS/ERK pathway, the serine/threonine kinase BRAF plays a key role ...
Despite the clinical success of BRAF inhibitors like vemurafenib in treating metastatic melanoma, re...
The RAF/MEK/ERK pathway is central to the control of cell physiology, and its dysregulation is assoc...
Tumors with mutant BRAF are dependent on the RAF/MEK/ERK signaling pathway for their growth1-3. We f...
The BRAF kinase, within the mitogen activated protein kinase (MAPK) signaling pathway, harbors activ...
Quantifying binding specificity and drug resistance of protein kinase inhibitors is of fundamental i...
Although RAF kinases are critical for controlling cell growth, their mechanism of activation is...